Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Chloroform Market: Fluorochemical HCFC-22 Intermediate Demand, Pharmaceutical Solvent and Extraction Growth, and High-Purity Analytical Application to Drive Above-Sector Market Expansion Through 2035

The global Chloroform Market was valued at USD 2.85 Billion in 2025 and is expected to reach USD 4.81 Billion by 2035, advancing at a CAGR of 6.0% through 2035. Chloroform (trichloromethane, CHCl3) — produced by chlorination of methane, methyl chloride, or acetaldehyde — is supplied in alcohol-stabilised, amylene-stabilised, and unstabilised forms at greater-than-99.5%, 99.0 to 99.5%, and below 99.0% purity tiers in technical, alcohol-stabilised, fluorocarbon, pharmaceutical, and analytical grades through direct sales, chemical distributors, and online B2B channels serving fluorochemical intermediate (HCFC-22 production, fluorochemical synthesis, refrigerant manufacturing), pharmaceutical (API manufacturing, pharmaceutical intermediate, drug discovery, laboratory), agrochemical (herbicide, fungicide, insecticide intermediates), solvent (pharmaceutical and laboratory solvent, chemical processing, extraction), and reagent (laboratory, analytical, R&D) applications across pharmaceutical manufacturers, agrochemical manufacturers, chemical manufacturers, specialty chemical producers, CROs, research institutions, and laboratories.

The chloroform market’s above-sector 6.0% CAGR reflects HCFC-22 refrigerant and fluoropolymer intermediate demand from air conditioning and fluorocarbon chain growth sustaining the largest application, pharmaceutical solvent and extraction demand from generic API manufacturing expansion in India and China, and high-purity analytical reagent demand from pharmaceutical QC and research laboratory growth sustaining structured chloroform market demand through 2035.

Executive Snapshot

How is HCFC-22 fluorochemical intermediate demand sustaining the largest chloroform application?
Chloroform as the primary commercial production intermediate for HCFC-22 (difluorochloromethane, CHClF2) — the widely used air conditioning and heat pump refrigerant and fluoropolymer PTFE and PVDF polymerisation monomer intermediate — sustains the largest-volume chloroform application from the scale of global HCFC-22 production for air conditioning equipment manufacturing. Each tonne of HCFC-22 requires approximately 1.2 tonnes of chloroform as the HF fluorination feedstock sustaining chloroform demand proportional to HCFC-22 and PTFE production volume at fluorochemical synthesis accounts.

What pharmaceutical solvent and extraction demand sustains chloroform specialty application?
Pharmaceutical chloroform as an extraction solvent for natural product isolation, API crystallisation solvent, and reaction medium for sensitive pharmaceutical intermediate synthesis sustains pharmaceutical-grade demand from the scale of global generic pharmaceutical API manufacturing in India and China. Chloroform high solvating power for organic pharmaceutical intermediates and immiscibility with water providing clean two-phase extraction at pharmaceutical synthesis laboratory and pilot plant accounts sustaining structured pharmaceutical-grade procurement.

How is agrochemical intermediate synthesis sustaining chloroform demand?
Chloroform as a solvent and intermediate for agrochemical synthesis — providing solvent medium for chlorinated herbicide and fungicide intermediate reaction and extraction — sustains agrochemical-grade demand from the scale of Asian agrochemical synthesis facility production. Chinese agrochemical synthesis consuming technical-grade chloroform for herbicide and fungicide intermediate extraction and reaction sustaining large-volume Asian chloroform demand from food security pesticide production.

What high-purity analytical and laboratory demand sustains chloroform specialty procurement?
High-purity deuterated chloroform (CDCl3, greater-than-99.8% isotopic purity) as the universal NMR spectroscopy solvent for pharmaceutical compound structure characterisation, analytical reagent-grade chloroform for pharmaceutical raw material and drug product dissolution testing, and HPLC mobile phase chloroform for pharmaceutical quality control chromatography sustain premium analytical-grade demand from pharmaceutical QC laboratory and research institution accounts.

How is pharmaceutical NMR solvent demand sustaining analytical chloroform specialty growth?
Deuterated chloroform (d-chloroform, CDCl3) as the dominant NMR solvent for organic compound structure elucidation — pharmaceutical drug candidate characterisation, natural product structure determination, and polymer molecular structure analysis — sustains premium-priced analytical chloroform demand from pharmaceutical R&D, CRO, and academic chemistry laboratory accounts consuming d-chloroform at sub-gram to multi-gram quantities per NMR analysis.

Which chloroform segments are growing fastest?
HCFC-22 fluoropolymer PTFE/PVDF intermediate from air conditioning and fluoropolymer growth, pharmaceutical API extraction and solvent from generic drug manufacturing, deuterated NMR analytical from pharmaceutical R&D, and agrochemical herbicide extraction from food security are the four fastest-growing segments.

Request Sample
Speak with an Analyst
Download TOC

Market Dynamics: Chloroform Market

  • Fluorocarbon Grade leads the By Grade fastest-growing sub-segment — HCFC-22 refrigerant and fluoropolymer intermediate from air conditioning and fluorocarbon chain demand.: Within the By Grade segmentation, Fluorocarbon/Refrigerant Grade represents the fastest-growing sub-segment from global HCFC-22 air conditioning refrigerant and PTFE/PVDF fluoropolymer intermediate production consuming chloroform at defined HF fluorination ratios.
  • Intermediates leads the By Application fastest-growing sub-segment — fluorochemical HCFC-22 intermediate sustains the largest and fastest-growing application from air conditioning and fluorocarbon scale.: Within the By Application segmentation, Intermediates — Fluorochemical Intermediates — represents the fastest-growing application from HCFC-22 and fluoropolymer production consuming chloroform as the primary production intermediate at fluorochemical synthesis facility scale.
  • Pharmaceutical leads the fastest-growing By End User industry sub-segment — API manufacturing and drug discovery chloroform solvent and extraction demand.: Within the By End User segmentation, Pharmaceutical — API Manufacturing, Drug Discovery R&D, Laboratory Testing — represents the fastest-growing end-user sub-segment from generic pharmaceutical API manufacturing growth sustaining pharmaceutical-grade solvent and extraction chloroform demand.
  • Greater than or equal to 99.5% Purity leads the fastest-growing By Purity segment — pharmaceutical and analytical grade high-purity demand sustaining premium tier growth.: Within the By Purity segmentation, Greater than or Equal to 99.5% represents the fastest-growing and highest-value tier from pharmaceutical API synthesis and analytical NMR and chromatography applications requiring above-technical-grade purity specification.
  • Alcohol-Stabilised leads the By Stabiliser segment — amylene or ethanol stabilised chloroform dominates pharmaceutical and laboratory supply from photodecomposition and phosgene prevention.: Within the By Stabiliser segmentation, Alcohol-Stabilised dominates from pharmaceutical and laboratory supply requiring ethanol or amylene stabiliser to prevent photodecomposition to toxic phosgene at dispensing and storage conditions.
  • Pharmaceutical Grade leads the By Grade segment by value — GMP-certified chloroform from pharmaceutical API synthesis and QC laboratory commands the highest commercial value above technical grade.: Within the By Grade segmentation, Pharmaceutical Grade commands the highest commercial value from GMP-certified pharmaceutical synthesis and quality control application requirements sustaining above-technical-grade pricing from analytical purity specification and regulatory documentation.

Market Segmentation: Chloroform Market

By Grade
  • Technical Grade
  • Alcohol Stabilized Grade
  • Fluorocarbon Grade
By Packaging
  • Laboratory Bottles
  • Cans & Containers
  • Drums
  • Intermediate Bulk Containers (IBCs)
  • Bulk Tankers
By Form
  • Liquid
  • Stabilized Liquid
  • High-Purity Liquid
  • Bulk Liquid
By Stabilizer
  • Alcohol-Stabilized
  • Amylene-Stabilized
  • Other Stabilized Grades
  • Unstabilized
By Sales Channel
  • Direct Sales
  • Chemical Distributors
  • Specialty Chemical Suppliers
  • Industrial Wholesalers
  • Online B2B Channels
By Purity
  • ≥99.5%
  • 99.0–99.5%
  • <99.0%
By Application
  • Solvent
    • Pharmaceutical Solvent
    • Laboratory Solvent
    • Chemical Processing Solvent
    • Extraction Solvent
    • Resin & Polymer Solvent
  • Intermediates
    • Fluorochemical Intermediates
    • Pharmaceutical Intermediates
    • Agrochemical Intermediates
    • Organic Chemical Intermediates
    • Specialty Chemical Intermediates
  • Reagent
    • Laboratory Reagent
    • Analytical Reagent
    • Research & Development
    • Chemical Synthesis
  • Others
    • Extraction & Separation
    • Chemical Manufacturing
    • Research Applications
    • Specialty Industrial Applications
By End User
  • Pharmaceutical
    • API Manufacturing
    • Pharmaceutical Intermediates
    • Drug Discovery & R&D
    • Laboratory Testing
  • Agrochemical
    • Herbicide Manufacturing
    • Fungicide Manufacturing
    • Insecticide Manufacturing
    • Crop Protection Chemical Intermediates
  • Chemical Industry
    • Fluorochemical Manufacturing
    • Organic Chemical Manufacturing
    • Specialty Chemicals
    • Chemical Intermediates
    • Polymer & Resin Processing
  • Others
    • Research Laboratories
    • Academic Institutions
    • Testing Laboratories
    • Electronics
    • Industrial Processing
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Chloroform Market

  1. HCFC-22 fluorochemical intermediate from air conditioning refrigerant and PTFE/PVDF fluoropolymer production.: Global HCFC-22 air conditioning and fluoropolymer production sustaining chloroform demand at defined HF fluorination intermediate ratios proportional to HCFC-22 production volume.
  2. Pharmaceutical API solvent and extraction from generic drug manufacturing in India and China.: Generic pharmaceutical API extraction solvent and reaction medium demand sustaining pharmaceutical-grade chloroform procurement from Indian and Chinese pharmaceutical synthesis accounts.
  3. Agrochemical herbicide and fungicide extraction from food security pesticide production.: Asian agrochemical herbicide and fungicide intermediate extraction sustaining technical-grade chloroform demand from food security pesticide synthesis facility accounts.
  4. Deuterated NMR chloroform analytical from pharmaceutical R&D and quality control laboratory.: CDCl3 pharmaceutical NMR structure characterisation sustaining premium analytical deuterated chloroform demand from pharmaceutical R&D and QC laboratory accounts.
  5. HCFC-22 to HFO transition timeline sustaining near-term chloroform demand from ACS refrigerant cycle.: HCFC-22 phase-down Kigali Amendment timeline sustaining near-term above-historical chloroform intermediate demand from HCFC-22 production before HFO transition completion.
  6. High-purity pharmaceutical grade from increasing GMP and ICH quality specification.: ICH Q3A/Q3B and pharmaceutical grade quality specification sustaining high-purity pharmaceutical chloroform demand from increasing GMP manufacturing accounts.

Regional Outlook: Chloroform Market

  • North America: The United States anchors North American demand from fluorochemical, pharmaceutical, and agrochemical industries. Honeywell, Chemours, and Sigma-Aldrich are major North American suppliers. U.S. HCFC-22 production sustains the largest fluorochemical chloroform demand. U.S. pharmaceutical API solvent and NMR analytical sustain specialty demand.
  • Europe: Germany, France, and Netherlands anchor European demand from pharmaceutical, fine chemical, and fluorochemical industries. Solvay, Arkema, and MilliporeSigma are major European suppliers. European pharmaceutical GMP solvent sustains the highest-value demand. EU HCFC-22 phase-down timeline sustaining transition-period production demand.
  • Asia-Pacific: China and India dominate Asia-Pacific chloroform production and consumption from HCFC-22 and agrochemical synthesis. China is the world’s largest chloroform producer from massive HCFC-22 and agrochemical manufacturing. Indian pharmaceutical generic API extraction solvent demand sustains growing pharmaceutical-grade procurement.

Competitive Landscape: Chloroform Market

Key Players: Honeywell (Fluorochemicals), Chemours Company, Solvay SA, Arkema SA, MilliporeSigma, Thermo Fisher Scientific, TCI Chemicals, Avantor (VWR), Strem Chemicals, Acros Organics, Brenntag, Univar Solutions, INEOS Group, Dow Inc., Sinopec, Juhua Group, Sigma-Aldrich, Oakwood Chemical

  • Honeywell [March 2026] confirmed commercial production of its HCFC-22 refrigerant and fluoropolymer intermediate products from chloroform fluorination feedstock at its fluorochemical manufacturing facilities, with Honeywell reporting that global air conditioning equipment manufacturing and PTFE and PVDF fluoropolymer intermediate demand from chemical processing and semiconductor application accounts are sustaining structured HCFC-22 and fluoropolymer production consuming chloroform at defined HF fluorination intermediate ratios at Honeywell’s North American and Asian fluorochemical production accounts.
  • Chemours Company [December 2025] reported commercial production of its fluorochemical products from chloroform intermediate for global refrigerant and fluoropolymer accounts, with Chemours noting that global HCFC-22 refrigerant demand from developing market air conditioning equipment and PVDF fluoropolymer demand from EV battery binder, semiconductor process, and chemical processing applications are collectively sustaining above-historical chloroform fluorochemical intermediate procurement from Chemours’s integrated fluorochemical chloroform-to-HCFC-22 and fluoropolymer production network.
  • MilliporeSigma [September 2025]  confirmed commercial supply of high-purity analytical, pharmaceutical, and deuterated chloroform-d (CDCl3) for global pharmaceutical R&D, quality control laboratory, and academic research accounts, with MilliporeSigma reporting that pharmaceutical drug candidate NMR structure characterisation, pharmaceutical QC dissolution testing, and academic organic synthesis research CDCl3 laboratory-grade demand are sustaining premium analytical chloroform procurement from MilliporeSigma’s high-purity solvent and deuterated solvent specialty supply accounts serving pharmaceutical and research laboratory markets.

Consultant POV

The Chloroform Market advancing at 6.0% CAGR through 2035 is anchored in HCFC-22 fluorochemical intermediate from air conditioning and fluoropolymer production, pharmaceutical API solvent and extraction from generic drug manufacturing, agrochemical herbicide synthesis, and deuterated NMR analytical from pharmaceutical R&D sustaining above-sector market expansion. Honeywell HCFC-22 fluorochemical chloroform intermediate production, Chemours fluoropolymer chloroform fluorochemical intermediate growth, and MilliporeSigma high-purity pharmaceutical and CDCl3 analytical chloroform demand confirm the chloroform market will sustain above-sector growth through 2035.

Request Sample
Speak with an Analyst
Download TOC

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

More Press Releases

Speak with an Analyst

    Download TOC

      Request a Sample Report